Search | SPORTIVO Network

rohit001 added blog Other
2026-06-03 12:08:42

Adalimumab Biosimilar Market Size, Share, Growth Trends, Industry Analysis, and Forecast 2026–2032 Driven by Rising Demand for Cost-Effective Biologic Therapies and Expanding Biosimilar Adoption
According to the latest report published by Data Bridge Market Research, the Adalimumab Biosimilar Market Data Bridge Market Research analyses that the adalimumab biosimilar market which is USD 598.30 million in 2022, is expected to reach USD 3431.48 million by 2030, at a CAGR of 24.4% during the forecast period 2023 to 2030. This Adalimumab Biosimilar Marketdocument provides with...

0 Comments 0 Shares 844 Views 0 Reviews

Please log in to like, share and comment!
rishika_2003 added blog Other
2026-06-11 09:13:05

Global Dupilumab Drug Market Expected to Reach USD 34.94 Billion by 2032 Amid Rising Demand for Advanced Biologic Therapies
According to a report by Intel Market Research, the global Dupilumab Drug Market was valued at USD 16,960 million in 2024 and is projected to reach USD 34,940 million by 2032, registering a CAGR of 11.2% during the forecast period. The market is experiencing substantial growth driven by the increasing prevalence of chronic inflammatory diseases, expanding regulatory approvals, growing adoption...

0 Comments 0 Shares 270 Views 0 Reviews

Please log in to like, share and comment!
stephengrey169 added blog Other
2026-06-05 13:19:51

North American Adalimumab Market Benefits from Expanding Access to Biologic Therapies
The global Adalimumab Market is witnessing significant growth, driven by the increasing burden of chronic inflammatory and autoimmune diseases worldwide. Adalimumab, a monoclonal antibody that targets tumor necrosis factor-alpha (TNF-α), has become one of the most widely prescribed biologic therapies due to its proven efficacy across multiple indications. According to The...

0 Comments 0 Shares 280 Views 0 Reviews

Please log in to like, share and comment!
stephengrey169 added blog Other
2026-06-05 13:20:04

North American Adalimumab Market Benefits from Expanding Access to Biologic Therapies
The global Adalimumab Market is witnessing significant growth, driven by the increasing burden of chronic inflammatory and autoimmune diseases worldwide. Adalimumab, a monoclonal antibody that targets tumor necrosis factor-alpha (TNF-α), has become one of the most widely prescribed biologic therapies due to its proven efficacy across multiple indications. According to The...

0 Comments 0 Shares 315 Views 0 Reviews

Please log in to like, share and comment!
stephengrey169 added blog Other
2026-06-29 13:49:21

US Tumor Necrosis Factor Inhibitor Drugs Market Growth Driven by Biologic Therapies
The US Tumor Necrosis Factor Inhibitor Drugs Market remains one of the largest and most mature biologics markets globally, driven by the high prevalence of autoimmune diseases such as rheumatoid arthritis, Crohn’s disease, ulcerative colitis, psoriatic arthritis, and plaque psoriasis. The United States benefits from advanced healthcare infrastructure, widespread access to specialty care,...

0 Comments 0 Shares 194 Views 0 Reviews

Please log in to like, share and comment!
Vanshika added blog Health
2026-06-01 07:44:13

Connective Tissue Disease Market Dynamics, Opportunities and Future Growth Prospects
Connective tissue diseases (CTDs) represent a group of autoimmune and inflammatory disorders that affect the body's connective tissues, including joints, skin, blood vessels, muscles, and internal organs. Rising awareness of autoimmune disorders, advancements in diagnostic technologies, increasing healthcare spending, and the introduction of innovative biologic therapies are contributing...

0 Comments 0 Shares 1K Views 0 Reviews

Please log in to like, share and comment!
rishika_2003 added blog Health
2026-03-18 09:15:31

Rising Demand for Orthopedic Drugs Drives Market Growth at 4.7% CAGR Through 2034
According to a new report from Intel Market Research, the global prescription orthopedic drugs market was valued at USD 5.8 billion in 2025 and is projected to reach USD 9.1 billion by 2034, growing at a steady CAGR of 4.7% during the forecast period (2026–2034). This sustained growth reflects an aging global population's increasing need for musculoskeletal treatments and continuous...

0 Comments 0 Shares 3K Views 0 Reviews

Please log in to like, share and comment!